The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / ACR Delegates Move Rheumatology Concerns Forward at AMA

ACR Delegates Move Rheumatology Concerns Forward at AMA

December 10, 2018 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

At the AMA’s recent House of Delegates Interim Meeting, the ACR’s delegation was able to incorporate rheumatology concerns into official AMA policy, in addition to leading a major multi-specialty resolution on the CMS-proposed move to consolidate and cut evaluation and management (E/M) services. The ACR is able to make this progress because members of the ACR join or renew their memberships in the AMA.

You Might Also Like
  • ACR Delegates Attend AMA House of Delegates Interim Meeting
  • AMA House of Delegates 2018 Annual Meeting Recap
  • Health Policy Resolutions from the AMA House of Delegates 2016 Interim Meeting
Also By This Author
  • ACR Seeks Members’ Help to Boost AMA Representation

Resolutions Passed
Gary Bryant, MD, chair of the ACR’s delegation to the AMA House of Delegates, reported the ACR submitted or co-sponsored several critical resolutions at the Interim HOD meeting, in November in National Harbor, Md. The ACR authored and led Resolution 227, which dealt with the CMS proposal in its 2019 proposed rule to consolidate and cut evaluation and management (E/M) services. The ACR obtained 19 co-sponsoring organizations to oppose this change, including other prominent specialties and state medical associations. Happily, due to intense advocacy by the ACR and other organizations, the CMS did not include the proposed cuts in the final rule published Nov. 1, and the ACR withdrew this resolution. The ACR stands ready to reintroduce it in the future, because the CMS may only delay this proposal.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Resolution 217 was submitted in coordination with the American Society of Clinical Oncology (ASCO) and the American Gastroenterology Association (AGA). It asked the AMA to advocate against Medicare changes that would recategorize Medicare Part B drugs as Part D. This was strongly supported and passed.

Similarly, Resolution 810 asked the AMA to continue strong advocacy against step therapy in Medicare Advantage plans and impede the implementation of the practice before it takes effect on Jan. 1, 2019. This was initially put on the reaffirmation calendar, but the ACR delegation and partners were able to successfully extract this and had the resolution passed to ensure prioritization in the AMA’s advocacy efforts.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The ACR also co-sponsored an ASCO resolution regarding the Medicare Part B Competitive Acquisition Program (CAP). We provided amended language that strengthened the initial proposal. The amended resolution asking that this program be voluntary and have some form of flexibility, remuneration for drug handling and complex care coordination, include vendor competition, and ultimately not interfering or delaying patient care was passed by the House.

Finally, the ACR co-sponsored Resolution 232 that would oppose any CMS mandatory licensing requirements for Qualified Clinical Data Registry (QCDR) measure owners. This was an important issue for QCDRs including the ACR’s RISE registry. We proposed amended language, which was accepted, that emphasized the importance of standards adhered to by others if they were to adopt our measures, ensuring integrity and validity of the measure. This was passed in amended form.

Pages: 1 2 | Single Page

Filed Under: Meeting Reports, Professional Topics Tagged With: AMA House of Delegates (HOD), American Gastroenterology Association (AGA), American Society of Clinical Oncology (ASCO), evaluation and management (E/M) services, House of Delegates interim meeting

You Might Also Like:
  • ACR Delegates Attend AMA House of Delegates Interim Meeting
  • AMA House of Delegates 2018 Annual Meeting Recap
  • Health Policy Resolutions from the AMA House of Delegates 2016 Interim Meeting
  • ACR Attends AMA House of Delegates

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)